 This study is a single center, non-randomized, open-label, pilot efficacy and safety study evaluating the ability of clevidipine IV antihypertensive to rapidly control elevated blood pressure BP in the setting of an acute aortic emergencies aneurysm, dissection or other aortic disease. 